2nd Annual Clinical Trials for Oncology
|Event Date/Time: Sep 26, 2011||End Date/Time: Sep 27, 2011|
But there is a growing field of knowledge and expertise, enabling the industryâ€™s leading players to maximise the chances of their cancer drugs succeeding in phase III and beyond. Many of them will be at Septemberâ€™s Clinical Trials for Oncology conference â€“ and many of the sectorâ€™s leading players will be presenting their work at the event.
This yearâ€™s event will focus on how you can bring your clinical trials in line with important developments in personalized medicine, targeted therapeutics and adaptive trial design. The agenda will show how the most innovative scientific concepts are actively being put into practice within the industry, enabling you to:
1. Understand how biomarkers are used in assessing drug effectiveness and accurately identify the biologically targeted sub-populations that will benefit from your treatment.
2. Know the regulatory and cultural requirements in various parts of the world, to take full advantage of the opportunities to run trials in emerging regions.
3. Drive patient recruitment and retention, expedite the ethics committee and contracting processes, promote the sites that are working efficiently and rehabilitate or close inefficient sites.
4. Efficiently test your combination therapeutics and prove that your drug can combine with other known toxic agents to have a substantial beneficial impact.
For more information or to register, simply:
Call: +1 212 537 5898